TY - JOUR
T1 - Trends in net survival from cervical cancer in six European Latin countries
T2 - Results from the SUDCAN population-based study
AU - GRELL EUROCARE-5 Working Group
AU - Haelens, Annemie
AU - Roche, Laurent
AU - Bastos, Joana
AU - Woronoff, Anne Sophie
AU - Zorzi, Manuel
AU - Francart, Julie
AU - Van Eycken, E.
AU - Henau, K.
AU - Velten, M.
AU - Bouvier, V.
AU - Launoy, G.
AU - Bouvier, A. M.
AU - Faivre, J.
AU - Woronoff, A. S.
AU - Robaszkiewicz, M.
AU - Tretarre, B.
AU - Bossard, N.
AU - Uhry, Z.
AU - Colonna, M.
AU - Molinié, F.
AU - Bara, S.
AU - Lapôtre-Ledoux, B.
AU - Grosclaude, P.
AU - Brenner, H.
AU - Katalinic, A.
AU - Mazzoleni, G.
AU - Bulatko, A.
AU - Buzzoni, C.
AU - Giacomin, A.
AU - Ferretti, S.
AU - Barchielli, A.
AU - Manneschi, G.
AU - Gatta, G.
AU - Sant, M.
AU - Amash, H.
AU - Amati, C.
AU - Baili, P.
AU - Berrino, F.
AU - Bonfarnuzzo, S.
AU - Botta, L.
AU - Capocaccia, R.
AU - Di Salvo, F.
AU - Foschi, R.
AU - Margutti, C.
AU - Meneghini, E.
AU - Minicozzi, P.
AU - Trama, A.
AU - Serraino, D.
AU - Zucchetto, A.
AU - Verne, J.
N1 - Funding Information:
The SUDCAN study was supported by the French Ligue contre le Cancer. The authors thank Ludivine Garrier (Registre des cancers digestifs de Bourgogne) for her technical assistance and Jean Iwaz (Service de Biostatistique des Hospices Civils de Lyon) for the final revision of the manuscript. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202).
Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Cancer survival is a key measure of the effectiveness of a healthcare system. As differences in healthcare systems are present among European Latin countries, it is of interest to look specifically at their similarities and differences in terms of cancer survival. Incident cases were extracted from the EUROCARE-V database for France, Italy, Spain, Switzerland, Portugal, and Belgium. One and 5-year net survivals (NS) were calculated for the period 2000-2004 using the Pohar-Perme estimator. Trends in NS over the 1992-2004 period and changes in the pattern of cancer excess mortality rate until 5 years after diagnosis were examined using a multivariate excess mortality rate model. There were moderate differences in age-standardized NS between countries (5-year NS range: 83-88%), but significant differences in the age groups 15-54 and 55-74 years (at 5 years up to +16 and +18% between any two countries). During the study period, excess mortality and NS improved in Italy, Spain, and Portugal. In Italy and Portugal, this improvement was slightly similar at ages 40, 55, and 70 whereas, in Spain, there was a sharp increase in NS at age 55. Because of this improvement, excess mortality and NS were similar in all six countries in 2004. Excess mortality peaked around 1 year after diagnosis in the youngest ages, but decreased gradually in the elderly. Detailed analyses showed differences in excess mortality and NS from cervical cancer between European Latin countries. However, these differences decreased over the study period because of the considerable improvement in Spain, Italy, and Portugal.
AB - Cancer survival is a key measure of the effectiveness of a healthcare system. As differences in healthcare systems are present among European Latin countries, it is of interest to look specifically at their similarities and differences in terms of cancer survival. Incident cases were extracted from the EUROCARE-V database for France, Italy, Spain, Switzerland, Portugal, and Belgium. One and 5-year net survivals (NS) were calculated for the period 2000-2004 using the Pohar-Perme estimator. Trends in NS over the 1992-2004 period and changes in the pattern of cancer excess mortality rate until 5 years after diagnosis were examined using a multivariate excess mortality rate model. There were moderate differences in age-standardized NS between countries (5-year NS range: 83-88%), but significant differences in the age groups 15-54 and 55-74 years (at 5 years up to +16 and +18% between any two countries). During the study period, excess mortality and NS improved in Italy, Spain, and Portugal. In Italy and Portugal, this improvement was slightly similar at ages 40, 55, and 70 whereas, in Spain, there was a sharp increase in NS at age 55. Because of this improvement, excess mortality and NS were similar in all six countries in 2004. Excess mortality peaked around 1 year after diagnosis in the youngest ages, but decreased gradually in the elderly. Detailed analyses showed differences in excess mortality and NS from cervical cancer between European Latin countries. However, these differences decreased over the study period because of the considerable improvement in Spain, Italy, and Portugal.
KW - Cancer registries
KW - Cervix uteri
KW - Europe
KW - Excess mortality rate
KW - Latin countries
KW - Net survival
KW - Trend analysis
UR - http://www.scopus.com/inward/record.url?scp=85010187548&partnerID=8YFLogxK
U2 - 10.1097/CEJ.0000000000000292
DO - 10.1097/CEJ.0000000000000292
M3 - Article
C2 - 28005611
AN - SCOPUS:85010187548
VL - 26
SP - S92-S99
JO - European Journal of Cancer Prevention
JF - European Journal of Cancer Prevention
SN - 0959-8278
IS - Trends in cancer net survival in six European Latin Countries...
ER -